Cystic Glioblastoma
- 1 January 2014
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurosurgery
- Vol. 74 (1), 71-76
- https://doi.org/10.1227/neu.0000000000000200
Abstract
Controversy exists regarding the prognostic significance of cystic features in newly diagnosed glioblastoma multiforme (GBM) and the pathological origin of cystic GBMs. To determine whether cystic GBMs develop from low-grade gliomas by evaluating IDH1 status and to evaluate the differences in overall survival between patients with cystic and noncystic tumors. We retrospectively reviewed the records of 351 consecutive newly diagnosed adult GBM patients treated at our institution from October 1997 to November 2011; patients with >50% cystic tumor composition were further identified. IDH1 mutation was determined by immunohistochemical staining. Patient characteristics and treatment were reported for cystic and noncystic tumors separately. Overall survival was reported for cystic and noncystic cohorts by using the Kaplan-Meier estimates. Of 351 patients, 27 (7.7%) had cystic tumors and 324 (92.3%) had noncystic tumors. Tumor samples for patients with cystic GBMs were immunohistochemically analyzed for IDH1 mutations. Two (7.4%) of the 27 tumor samples were documented as having IDH1 mutations. Characteristics such as age, sex, perioperative Karnofsky Performance Status, tumor size, extent of resection, postsurgery radiation, and temozolomide therapy were comparable in the and noncystic cohorts. Patients in the cystic cohort had a median overall survival of 15.0 months compared with 18.2 months for the noncystic cohort (log-rank P = .77). The low frequency of IDH1 mutation status in our cystic cohort strongly suggests that most newly diagnosed cystic GBMs do not arise from malignant transformation of previously undiagnosed low-grade gliomas. Furthermore, there is no difference in overall survival between patients newly diagnosed with cystic and noncystic GBMs.Keywords
This publication has 26 references indexed in Scilit:
- IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomasNeuro-Oncology, 2009
- IDH1andIDH2Mutations in GliomasThe New England Journal of Medicine, 2009
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- Pathological and clinical features of cystic and noncystic glioblastomasBrain Tumor Pathology, 2006
- Different angiogenic phenotypes in primary and secondary glioblastomasInternational Journal of Cancer, 2005
- Brain stem glioblastoma with multiple large cyst formation and leptomeningeal dissemination in a 4-year-old girlBrain & Development, 2005
- Cystic glioblastoma multiforme: survival outcomes in 22 casesJournal of Neurosurgery, 2004
- Discrimination of Brin Abscess and Cystic Tumor by In Vivo Proton Magnetic Resonance Spectroscopy.Neurologia medico-chirurgica, 2001
- Primary and secondary glioblastomas: From concept to clinical diagnosisNeuro-Oncology, 1999
- Cysts in malignant gliomasJournal of Neurosurgery, 1980